Skip to main content
. Author manuscript; available in PMC: 2017 Jan 12.
Published in final edited form as: J Clin Oncol. 2009 Jun 8;27(21):3452–3458. doi: 10.1200/JCO.2008.20.0923

Table 1.

Characteristics of ADT Users and Nonusers in Matched Cohort at Index Date

Characteristic ADT Users (%; n = 19,079) ADT Nonusers (%; n = 19,079)
Age, years
 Mean 75.0
 SD 6.3

Collapsed ambulatory diagnostic group
 Acute minor 79.0 80.0
 Acute major 84.4 84.1
 Likely to recur (includes myocardial infarction) 78.9 78.6
 Asthma 6.2 6.9
 Chronic medical unstable 92.9 92.3
 Chronic medical stable (includes hypertension and diabetes) 84.2 84.3
 Chronic specialty unstable 17.3 17.5
 Chronic specialty stable 8.7 9.3
 Eye/dental 28.2 29.0
 Psychosocial 33.9 34.1
 Prevention, administration 32.3 32.3

Use of bone-thinning medication 8.9 9.6

Prior bone mineral density test 3.1 3.1

Prior diagnosis of osteoporosis 4.5 4.6

Prior fragility fracture 3.1 3.4

Prior prostate cancer treatment
 Radical prostatectomy 6.5 6.5

Rural/small town 17.7 17.2

Income quintile
 1 (highest) 17.5 18.3
 2 16.0 15.9
 3 16.7 16.9
 4 17.0 17.0
 5 (lowest) 14.0 13.7

At least 51% of primary care visits to same physician 60.3 61.8

Abbreviations: ADT, androgen deprivation therapy; SD, standard deviation.